These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33612761)

  • 1. Assessment of interleukin 17 and transforming growth factor-beta 1 in hepatitis C patients with disease progression.
    Elbanan WK; Fathy SA; Ibrahim RA; Hegazy MGA
    Trop Biomed; 2020 Dec; 37(4):1093-1104. PubMed ID: 33612761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival.
    Yu X; Guo R; Ming D; Deng Y; Su M; Lin C; Li J; Lin Z; Su Z
    Clin Vaccine Immunol; 2015 May; 22(5):484-92. PubMed ID: 25716231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus-Related Liver Cirrhosis.
    Ming D; Yu X; Guo R; Deng Y; Li J; Lin C; Su M; Lin Z; Su Z
    Viral Immunol; 2015 May; 28(4):209-16. PubMed ID: 25710085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive liver fibrosis markers: use of serum levels of cytokines IL 1α and TGF ß1 in management of chronic liver diseases.
    Mehmedović A; Mesihović R; Prnjavorac B; Vanis N; Vukobrat-Bijedić Z; Borovac N; Zubčević N; Pilav A; Gornjaković S; Kulo-Ćesić A; Mujarić E; Saray A
    Med Glas (Zenica); 2013 Feb; 10(1):20-7. PubMed ID: 23348156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Signal Transducer and Activator of Transcription 5 and Transforming Growth Factor-β1 in Hepatic Fibrosis Induced by Chronic Hepatitis C Virus Infection in Egyptian Patients.
    Abu El Makarem MA; El-Sagheer GM; Abu El-Ella MA
    Med Princ Pract; 2018; 27(2):115-121. PubMed ID: 29402841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage?
    Burra P; Masier A; Morisco F; Di Leo V; Zorzi M; Senzolo M; Marchini F; Guido M; Canova D; Floreani A; Burroughs AK
    Dig Liver Dis; 2008 Oct; 40(10):827-33. PubMed ID: 18372225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ratios of regulatory T cells/T-helper 17 cells and transforming growth factor-β1/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis.
    Yu X; Guo R; Ming D; Su M; Lin C; Deng Y; Lin Z; Su Z
    J Gastroenterol Hepatol; 2014 May; 29(5):1065-72. PubMed ID: 24236690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.
    El Bassuoni MA; Talaat RM; Ibrahim AA; Shaker OT
    Egypt J Immunol; 2008; 15(1):39-50. PubMed ID: 20306668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
    El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
    MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The imbalance of peripheral interleukin-18 and transforming growth factor-β1 levels in patients with cirrhosis and esophageal varices.
    Swidnicka-Siergiejko A; Wereszczynska-Siemiatkowska U; Siemiatkowski A; Wasielica-Berger J; Janica J; Mroczko B; Dabrowski A
    Cytokine; 2019 Jan; 113():440-445. PubMed ID: 30392846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis.
    Gewaltig J; Mangasser-Stephan K; Gartung C; Biesterfeld S; Gressner AM
    Clin Chim Acta; 2002 Feb; 316(1-2):83-94. PubMed ID: 11750277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
    Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
    Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis.
    Clemente M; Núñez O; Lorente R; Rincón D; Matilla A; Salcedo M; Catalina MV; Ripoll C; Iacono OL; Bañares R; Clemente G; García-Monzón C
    J Viral Hepat; 2006 Sep; 13(9):625-32. PubMed ID: 16907850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
    Gao Y; Ren H; Meng F; Li J; Cheung E; Li H; Zhao J; Liu H; Liu Z; Zhang M
    PLoS One; 2016; 11(4):e0154419. PubMed ID: 27123854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of transforming growth factor beta1 (TGF-beta1) in the pathogenesis and clinical course of chronic hepatitis in children].
    Liberek A; Marek A; Kmieć Z; Kartanowicz D; Szlagatys-Sidorkiewicz A; Łuczak G; Wierzbicki PM; Stanisławowski M; Wierzbicki M; Marek K; Liberek T; Sikorska-Wiśniewska G; Góra-Gebka M; Wegrzyn G; Kamińska B
    Med Wieku Rozwoj; 2009; 13(3):163-70. PubMed ID: 20081261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
    Ouda SM; Khairy AM; Sorour AE; Mikhail MN
    Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease.
    Eurich D; Bahra M; Boas-Knoop S; Lock JF; Golembus J; Neuhaus R; Neuhaus P; Neumann UP
    Liver Transpl; 2011 Mar; 17(3):279-88. PubMed ID: 21384510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.